share_log

MEDIROM Healthcare Technologies | 20-F: FY2023 Annual Report

メディロム・ヘルスケア・テクノロジーズ | 20-F:FY 2023 年度報告書

SEC ·  2024/06/18 17:33

Moomoo AIのまとめ

MEDIROM Healthcare Technologies Inc. reported financial results for the fiscal year ended December 31, 2023, with total revenue decreasing 1.8% to ¥6.83 billion. The Relaxation Salon segment revenue grew 1.5% to ¥6.06 billion, while Digital Preventative Healthcare revenue declined 48.1% to ¥200 million. The company sold 30 salons to investors in 2023 as part of its asset-light strategy.Operating loss was ¥392 million compared to operating income of ¥97 million in 2022, primarily due to increased costs and professional fees. However, the company recorded net income of ¥115 million, supported by ¥414 million in gains from salon sales. The company maintained a network of 314 relaxation salons as of year-end, with 180 directly operated salons and 96 franchised locations.Looking ahead, MEDIROM aims to accelerate growth through its salon sales and management contract model while expanding the Digital Preventative Healthcare segment. The company faces working capital constraints but plans to address liquidity needs through additional salon sales and debt refinancing. In April 2024, MEDIROM announced plans to acquire Japan Gene Medicine Corporation for ¥2.4 billion to enhance its healthcare services portfolio.
MEDIROM Healthcare Technologies Inc. reported financial results for the fiscal year ended December 31, 2023, with total revenue decreasing 1.8% to ¥6.83 billion. The Relaxation Salon segment revenue grew 1.5% to ¥6.06 billion, while Digital Preventative Healthcare revenue declined 48.1% to ¥200 million. The company sold 30 salons to investors in 2023 as part of its asset-light strategy.Operating loss was ¥392 million compared to operating income of ¥97 million in 2022, primarily due to increased costs and professional fees. However, the company recorded net income of ¥115 million, supported by ¥414 million in gains from salon sales. The company maintained a network of 314 relaxation salons as of year-end, with 180 directly operated salons and 96 franchised locations.Looking ahead, MEDIROM aims to accelerate growth through its salon sales and management contract model while expanding the Digital Preventative Healthcare segment. The company faces working capital constraints but plans to address liquidity needs through additional salon sales and debt refinancing. In April 2024, MEDIROM announced plans to acquire Japan Gene Medicine Corporation for ¥2.4 billion to enhance its healthcare services portfolio.
これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報